ec2
 

David
Faxon

Renowned Cardiologist and Educator - Dr. David Faxon

Boston, Massachusetts

Considered a leader in the medical field and an expert in his specialization of cardiology, David Faxon is a preeminent physician with a reputation for skilled patient care and knowledgeable treatment and diagnosis of heart-related medical conditions. Having served as a clinician, professor, and administrator for 40 years, David Faxon continues to build on experience by providing leadership to the Boston medical community.

A graduate of Boston University School of Medicine, David Faxon dedicates much of his time to instructing medical students as a lecturer and professor. At his alma mater, David Faxon taught “Clinical Pathologic Correlation” for second-year students and presented two-hour lectures on such topics as “Congestive Heart Failure” and “Coronary Artery Disease.” He has also served in a professorial role at the University of Chicago, where he taught a “Clinical Pathophysiological” course to second-year medical students. Under the direction of David Faxon, this class included a one-hour lecture on coronary artery disease and a two-hour laboratory case discussion. In addition, David Faxon presented a Senior Cardiology Lecture Series to fourth-year medical students at the University of Chicago.

David Faxon also works with graduate medical students. At Boston University Medical Center, he provided mentoring and advice to fellows and faculty at the school in weekly one-hour Cardiology Cardiac Surgery Conferences. Other graduate level teaching efforts performed by David Faxon included core curriculum seminars and conferences on angioplasty and coronary artery disease. While teaching at the University of Chicago and serving in a clinical and administrative capacity at its teaching hospital, David Faxon lectured on cardiology-related topics and took medical students, interns, and residents on rounds.

A frequent lecturer at professional conferences, over the past 35 years David Faxon has informed fellow cardiologists and physicians about new technologies and treatment methods in such venues as the Transcatheter Cardiovascular Therapeutics Symposium ; the American College of Cardiology Annual Scientific Sessions ; and the American Heart Association Scientific Sessions .

Currently an Attending Physician at Brigham and Women’s Hospital in Boston, David Faxon also serves as Vice Chair of Medicine for Strategic Planning for that institution.


David Faxon's Schools

David Faxon's Companies

David Faxon's Publications

  • Overview of Restenosis, David Faxon
    October, 2011
    by Dr. David Faxon

    The term “restenosis” describes the recurrence of a stenosis following angioplasty. Stenosis is a narrowing of an artery leading to a decrease in blood flow to an organ. When it occurs in the coronary arteries around the heart it can lead to chest pain often called angina or a heart attack.

    A great deal of clinical study has gone into understanding the disease process that leads to restenosis. Patients who have undergone angioplasty to increase blood flow through a blocked artery may be vulnerable to restenosis. Angioplasty causes damage to the arteries in the process of treating blockages, and restenosis is a excessive healing response to the trauma caused by the surgery that leads to the renarrowing. There are now number of treatment options to prevent and treat restenosis.

    In the past 20 years, the number of cases of restenosis has increased as the result of treatment of more advanced coronary artery disease. However, since the mid-1990s, the use of drug-eluting stents (DES) has played a significant part in reducing the incidence of restenosis. A stent is a metalic mesh tube. It is inserted into an artery to provide support and structure, allowing the vessel to remain open and blood to flow freely. Drug-eluting stents (DES) have further increased the efficacy of this technology. DES utilizes a system in which a stent coated with a drug, once in place, slowly releases drugs that inhibit cell growth and inflamation reducing the risk of restenosis. Other treatments for alleviating restenosis include repeat angioplasty, intravascular radiation therapy and coronary artery bypass grafts.

    Dr. David Faxon, a 40-year veteran in the medical field, has worked extensively in the research and treatment of heart disease. Dr. Faxon maintains membership in the American Heart Association and is the founding Editor of the organization’s publication, My American Heart Clinical Updates and Circulation: Cardiovascular Interventions.